COVID-19 vaccine may be ready by year-end: WHO’s Tedros

FILE PHOTO: World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus attends a news conference organized by Geneva Association of United Nations Correspondents (ACANU) amid the COVID-19 outbreak, caused by the novel coronavirus, at the WHO headquarters in Geneva Switzerland July 3, 2020. Fabrice Coffrini/Pool via REUTERS

By Stephanie Nebehay

GENEVA (Reuters) – A vaccine against COVID-19 may be ready by year-end, the head of the World Health Organization (WHO) said on Tuesday, without elaborating.

WHO Director-General Tedros Adhanom Ghebreyesus called for solidarity and political commitment by all leaders to ensure equal distribution of vaccines when they become available.

“We will need vaccines and there is hope that by the end of this year we may have a vaccine. There is hope,” Tedros said in closing remarks to the WHO’s Executive Board meeting that examined the global response to the pandemic.

The EU health regulator has launched a real-time review of a COVID-19 vaccine developed by U.S. drugmaker Pfizer and Germany’s BioNTech, it said on Tuesday, following a similar announcement for rival AstraZeneca’s jab last week. The announcement by the European Medicines Agency (EMA) could speed up the process of approving a successful vaccine in the bloc.

Nine experimental vaccines are in the pipeline of the WHO-led COVAX global vaccine facility that aims to distribute 2 billion doses by the end of 2021.

So far some 168 countries have joined the COVAX facility, but neither China, the United States nor Russia are among them. The Trump administration has said it is relying instead on bilateral deals to secure supplies from vaccine makers.

“Especially for the vaccines and other products which are in the pipeline, the most important tool is political commitment from our leaders especially in the equitable distribution of the vaccines,” Tedros said.

“We need each other, we need solidarity and we need to use all the energy we have to fight the virus,” he said.

(Reporting by Stephanie Nebehay in Geneva; Editing by Michael Shields and Alexandra Hudson)

Leave a Reply